Progranulin Protects Hippocampal Neurogenesis via Suppression of Neuroinflammatory Responses Under Acute Immune Stress

• Published in: Molecular neurobiology 2017-07, Vol.54 (5), p.3717-3728
• Main Authors: Ma, Yanbo, Matsuwaki, Takashi, Yamanouchi, Keitaro, Nishihara, Masugi
• Format: Article
• Language: English
• Subjects: Animals; Biomedical and Life Sciences; Biomedicine; Brain; Cell Biology; Dentate gyrus; Gene expression; Hippocampus; Hippocampus - metabolism; Hippocampus - pathology; Immune system; Inflammation; Inflammation - genetics; Inflammation - immunology; Inflammation - metabolism; Inflammation - pathology; Intercellular Signaling Peptides and Proteins - deficiency; Intercellular Signaling Peptides and Proteins - metabolism; Interleukin 1; Interleukin 6; Lipopolysaccharides; Lysosomes - metabolism; Lysozyme; Macrophages; Male; Mice; Mice, Inbred C57BL; Microglia; Microglia - metabolism; Microglia - pathology; Neurobiology; Neurogenesis; Neurology; Neurosciences; Prostaglandin E; Prostaglandin-E synthase; Rapamycin; Rodents; Signal Transduction; Stress; Stress, Physiological - immunology; TOR protein; TOR Serine-Threonine Kinases - metabolism; Traumatic brain injury
• ISSN: 0893-7648; 1559-1182
• DOI: 10.1007/s12035-016-9939-6

Immune stress is well known to suppress adult neurogenesis in the hippocampus. We have demonstrated that progranulin (PGRN) has a mitogenic effect on neurogenesis under several experimental conditions. We have also shown that PGRN suppresses excessive neuroinflammatory responses after traumatic brain injury. However, the role of PGRN in modulating neurogenesis under acute immune stress is yet to be elucidated. In the present study, we evaluated the involvement of PGRN in neurogenesis and inflammatory responses in the hippocampus using a lipopolysaccharide (LPS)-induced immune stress model. Treatment of mice with LPS significantly increased the expression of PGRN in activated microglia and decreased neurogenesis in the dentate gyrus of the hippocampus. PGRN deficiency increased CD68-immunoreactive area and exacerbated suppression of neurogenesis following LPS treatment. The expression levels of lysosomal genes including lysozyme M, macrophage expressed gene 1, and cathepsin Z were higher in PGRN-deficient than in wild-type mice, while PGRN deficiency decreased mammalian target of rapamycin (mTOR) mRNA levels, suggesting that PGRN suppresses excessive lysosomal biogenesis by promoting mTOR signaling. LPS treatment also increased the expression of proinflammatory genes such as interleukin (IL)-1β, tumor necrosis factor-α, and microsomal prostaglandin E synthase-1 (mPGES-1) in the hippocampus, and PGRN deficiency further enhanced gene expression of IL-6 and mPGES-1. These results suggest that PGRN plays a protecting role in hippocampal neurogenesis at least partially by attenuating neuroinflammatory responses during LPS-induced acute immune stress.